Singh Prabhdeep
Known title: Chief Growth OfficerCIK: 0001870027
Associated companies
Transaction History
| CLOV | ▲ Buy | Grant | 353,356 | $0 | 9/16/2022 | View on chart |
| CLOV | ▲ Buy | Grant | 255,474 | $0 | 3/14/2022 | View on chart |
| CLOV | ▲ Buy | Grant | 353,356 | $0 | 9/16/2022 | View on chart |
| CLOV | ▲ Buy | Grant | 255,474 | $0 | 3/14/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating
Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.